Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity

Michael Asamoah-Boaheng; David Goldfarb; Martin A. Prusinkiewicz; Liam Golding; Mohammad E. Karim; Vilte  Barakauskas; Nechelle  Wall; Agatha N. Jassem; Ana Citlali  Marquez; Chris MacDonald; Sheila F. O’Brien; Pascal  Lavoie; Brian Grunau; Michael Asamoah-Boaheng; David Goldfarb; Martin A. Prusinkiewicz; Liam Golding; Mohammad Ehsanul Karim; Vilte  E. Barakauskas; Nechelle  Wall; Agatha N. Jassem; Ana Citlali  Marquez; Christopher B. MacDonald; Sheila O’Brien; Pascal  Lavoie; Brian Grunau

doi:10.7759/cureus.34465

Enter your email address to receive your free PDF download.

Please note that by doing so you agree to be added to our monthly email newsletter distribution list.

Sign up for Cureus

or

First name

Last name

Email

Password

Specialty

Email Communication and Personal Data

Cureus personal data will never be sold to third parties and will only be used to enrich the user experience and contact you in direct relation to the application. I agree to opt in to this communication.

Learn more

Learn more

Download Media Kit

Learn more

Learn more

Ongoing Competitions

Enter your email address to receive your free PDF download.

Sign in to Cureus

Sign up for Cureus

Email Communication and Personal Data

Download Cureus Media Kit